- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0013072

AI Di Pharmaceuticals Private Limited
About AI Di Pharmaceuticals Private Limited
Data last updated:
AI Di Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 28 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52390DL2015PTC279566. Its GSTIN is 07AANCA4165C1ZT (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Asmara India Marketing Private Limited. It is led by directors Vandana Parikh and Kirit Parikh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office No. 7 1 Nirman Vihar Vikas Marg, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.49 Lakh, a growth of 93% compared to the previous year. For the same year it recorded a net profit of ₹19,908 (net margin 1.4%) and EBITDA of ₹45,728 (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 214% over three years and 5% over five years.
AI Di Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0013072). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of AI Di Pharmaceuticals
Contact details
AI Di Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. 7 1 Nirman Vihar Vikas Marg, Delhi, India – 110092
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of AI Di Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of AI Di Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of AI Di Pharmaceuticals Private Limited, buy the company report.
Financials of AI Di Pharmaceuticals Private Limited
FY 2024 filings availableAI Di Pharmaceuticals Private Limited reported revenue of ₹14.49 Lakh (up 93% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 93% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45,728 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,908 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of AI Di Pharmaceuticals Private Limited, buy the company report.
Board of directors of AI Di Pharmaceuticals Private Limited
AI Di Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Parikh | Director | 11 Mar 2020 | 6 Years 8 Months | Current |
| Kirit Parikh | Director | 28 Apr 2015 | 11 Years 6 Months | Current |
Auditor
AI Di Pharmaceuticals Private Limited is audited by SHIROMANY TYAGI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIROMANY TYAGI & CO | FY 2023 | 006117N |
Shareholding
The shareholding of AI Di Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of AI Di Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving AI Di Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for AI Di Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
AI Di Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCA4165C1ZT | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of AI Di Pharmaceuticals Private Limited, buy the company report.
Recent activity
AI Di Pharmaceuticals Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Vandana Parikh ceased to be Director Appointed In Casual Vacancy on 14 Aug 2020.
Frequently asked questions
AI Di Pharmaceuticals is an active private limited company based in Delhi, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 28 April 2015 (11+ years old) and is registered under CIN U52390DL2015PTC279566.
AI Di Pharmaceuticals has 2 current directors:
- Vandana Parikh - Director
- Kirit Parikh - Director
The latest financial statements of AI Di Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of AI Di Pharmaceuticals is 07AANCA4165C1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of AI Di Pharmaceuticals is U52390DL2015PTC279566. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
AI Di Pharmaceuticals was incorporated on 28 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Vandana Parikh ceased to be Director Appointed In Casual Vacancy on 14 Aug 2020. Devinder Pal Singh ceased to be Director on 11 Mar 2020. Vandana Parikh was appointed as Director on 11 Mar 2020. AI Di Pharmaceuticals has 4 board changes on record in total.
Yes, AI Di Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0013072).
The registered office of AI Di Pharmaceuticals is at Office No. 7 1 Nirman Vihar Vikas Marg, Delhi, India – 110092.
AI Di Pharmaceuticals operates in the FMCG industry, in the personal care and skincare products segment.

